Pope Leo XIV underwent successful thoracic surgery at Rome's Agostino Gemelli Polyclinic Hospital on Tuesday afternoon, where surgeons removed the lower lobe of his right lung after intraoperative histological examinations confirmed a diagnosis of pulmonary adenocarcinoma, a form of lung cancer. The surgical procedure, led by Gemelli's chief thoracic surgeon Dr. Stefano Margaritora and assisted by a specialized surgical and anesthesiology team, lasted approximately 90 minutes within a three-hour operating room window. The Holy See Press Office confirmed that the video-assisted lobectomy was carried out radically to excise all suspect tissue and concluded without complications, with the pontiff waking normally before returning to his hospital room on the 10th floor.

The intervention came just two days after the American pontiff broke precedent by directly informing pilgrims in St. Peter's Square during his Sunday Angelus address that physicians had identified a small, localized nodule in his lung. Holy See Press Office Director Matteo Bruni reported that the pontiff was alert following the procedure, ate dinner, and spent the evening working alongside his personal secretaries. While oncologists highlighted that detecting and removing the lesion at an early stage typically offers an encouraging prognosis, the diagnosis has drawn intense scrutiny toward the 71-year-old pontiff's health, particularly following statements from his elder brother, Louis Prevost, who noted a family history of oncological illness but expressed firm confidence in the Pope's endurance and swift recovery.

The unexpected health scare carries immediate ramifications for the governance of the 1.4-billion-member Catholic Church, halting official Vatican audiences through at least October 20. Catholic dioceses across the globe have initiated prayer vigils while international observers closely monitor whether the pontiff's expected one-week hospitalization and ensuing convalescence will disrupt his diplomatic agenda, notably a major scheduled apostolic tour across Uruguay, Argentina, and Peru slated for early November. Vatican authorities indicated that subsequent histological analyses will determine whether post-operative treatments such as chemotherapy are warranted.